UNIGE document Scientific Article
previous document  unige:1856  next document
add to browser collection
Title

Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants

Authors
Buller, Harry R.
Halperin, J L.
Prins, M.
Published in Journal of Thrombosis and Haemostasis. 2008, vol. 6, no. 2, p. 227-9
Keywords Anticoagulants/standards/therapeutic useBias (Epidemiology)Case ManagementClinical Trials, Phase III as Topic/methods/standardsCost-Benefit AnalysisDouble-Blind MethodFibrinolytic Agents/standards/therapeutic useHeparin/therapeutic useHeparin, Low-Molecular-Weight/therapeutic useHumansPatient SelectionProfessional PracticeProthrombin Time/instrumentationQuality of LifeRandomized Controlled Trials as Topic/methods/standardsThrombophilia/drug therapyTreatment OutcomeVitamin K/antagonists & inhibitors
Identifiers
PMID: 18034770
Full text
Structures
Research groups Geneva Platelet Group (13)
La maladie thromboembolique veineuse (808)
Citation
(ISO format)
BULLER, Harry R. et al. Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants. In: Journal of Thrombosis and Haemostasis, 2008, vol. 6, n° 2, p. 227-9. https://archive-ouverte.unige.ch/unige:1856

210 hits

0 download

Update

Deposited on : 2009-06-02

Export document
Format :
Citation style :